Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma

Elif Hindié
JCO. 2021-03-10; 39(8): 943-944
DOI: 10.1200/JCO.20.03213

PubMed
Lire sur PubMed



Hindié E(1).

Author information:
(1)Elif Hindi00B4 e, MD, PhD, Department of Nuclear Medicine, Bordeaux University
Hospital, Bordeaux, France.

DOI: 10.1200/JCO.20.03213
PMID: 33492983

Auteurs Bordeaux Neurocampus